BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 20638779)

  • 1. miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2.
    Ma Y; Yu S; Zhao W; Lu Z; Chen J
    Cancer Lett; 2010 Dec; 298(2):150-8. PubMed ID: 20638779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer.
    Hao J; Zhang S; Zhou Y; Hu X; Shao C
    FEBS Lett; 2011 Jan; 585(1):207-13. PubMed ID: 21112326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin.
    Liu T; Tang H; Lang Y; Liu M; Li X
    Cancer Lett; 2009 Jan; 273(2):233-42. PubMed ID: 18789835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development.
    Zhang S; Hao J; Xie F; Hu X; Liu C; Tong J; Zhou J; Wu J; Shao C
    Carcinogenesis; 2011 Aug; 32(8):1183-9. PubMed ID: 21665894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration.
    Sarver AL; Li L; Subramanian S
    Cancer Res; 2010 Dec; 70(23):9570-80. PubMed ID: 21118966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells.
    Liu M; Lang N; Chen X; Tang Q; Liu S; Huang J; Zheng Y; Bi F
    Cancer Lett; 2011 Feb; 301(2):151-60. PubMed ID: 21186079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
    Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
    Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.
    Chao A; Lin CY; Lee YS; Tsai CL; Wei PC; Hsueh S; Wu TI; Tsai CN; Wang CJ; Chao AS; Wang TH; Lai CH
    Oncogene; 2012 Feb; 31(6):764-75. PubMed ID: 21725366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer.
    Tsang WP; Ng EK; Ng SS; Jin H; Yu J; Sung JJ; Kwok TT
    Carcinogenesis; 2010 Mar; 31(3):350-8. PubMed ID: 19926638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells.
    Östling P; Leivonen SK; Aakula A; Kohonen P; Mäkelä R; Hagman Z; Edsjö A; Kangaspeska S; Edgren H; Nicorici D; Bjartell A; Ceder Y; Perälä M; Kallioniemi O
    Cancer Res; 2011 Mar; 71(5):1956-67. PubMed ID: 21343391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.
    Salvi A; Sabelli C; Moncini S; Venturin M; Arici B; Riva P; Portolani N; Giulini SM; De Petro G; Barlati S
    FEBS J; 2009 Jun; 276(11):2966-82. PubMed ID: 19490101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells.
    Li Z; Hu S; Wang J; Cai J; Xiao L; Yu L; Wang Z
    Gynecol Oncol; 2010 Oct; 119(1):125-30. PubMed ID: 20624637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein tyrosine phosphatase PTPRJ is negatively regulated by microRNA-328.
    Paduano F; Dattilo V; Narciso D; Bilotta A; Gaudio E; Menniti M; Agosti V; Palmieri C; Perrotti N; Fusco A; Trapasso F; Iuliano R
    FEBS J; 2013 Jan; 280(2):401-12. PubMed ID: 22564856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of miR-27a contributes to the malignant transformation of human bronchial epithelial cells induced by SV40 small T antigen.
    Wang Q; Li DC; Li ZF; Liu CX; Xiao YM; Zhang B; Li XD; Zhao J; Chen LP; Xing XM; Tang SF; Lin YC; Lai YD; Yang P; Zeng JL; Xiao Q; Zeng XW; Lin ZN; Zhuang ZX; Zhuang SM; Chen W
    Oncogene; 2011 Sep; 30(36):3875-86. PubMed ID: 21460851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The microRNA profile of prostate carcinoma obtained by deep sequencing.
    Szczyrba J; Löprich E; Wach S; Jung V; Unteregger G; Barth S; Grobholz R; Wieland W; Stöhr R; Hartmann A; Wullich B; Grässer F
    Mol Cancer Res; 2010 Apr; 8(4):529-38. PubMed ID: 20353999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer.
    Weiss FU; Marques IJ; Woltering JM; Vlecken DH; Aghdassi A; Partecke LI; Heidecke CD; Lerch MM; Bagowski CP
    Gastroenterology; 2009 Dec; 137(6):2136-45.e1-7. PubMed ID: 19747919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-196a binding-site SNP regulates RAP1A expression contributing to esophageal squamous cell carcinoma risk and metastasis.
    Wang K; Li J; Guo H; Xu X; Xiong G; Guan X; Liu B; Li J; Chen X; Yang K; Bai Y
    Carcinogenesis; 2012 Nov; 33(11):2147-54. PubMed ID: 22859270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-378a-5p promotes trophoblast cell survival, migration and invasion by targeting Nodal.
    Luo L; Ye G; Nadeem L; Fu G; Yang BB; Honarparvar E; Dunk C; Lye S; Peng C
    J Cell Sci; 2012 Jul; 125(Pt 13):3124-32. PubMed ID: 22454525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Target prediction and verification of miR-27a in pancreatic cancer].
    Zhang TT; Sun Y; Jia CW; Yu SN; Lu ZH; Chen J
    Zhonghua Bing Li Xue Za Zhi; 2013 Jun; 42(6):392-6. PubMed ID: 24060073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene.
    Ohuchida K; Mizumoto K; Lin C; Yamaguchi H; Ohtsuka T; Sato N; Toma H; Nakamura M; Nagai E; Hashizume M; Tanaka M
    Ann Surg Oncol; 2012 Jul; 19(7):2394-402. PubMed ID: 22407312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.